Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Open in API
Filings indexed 1,760 across all filing types
Latest filing 2026-06-01 Regulatory Filings
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
BRSR 2025-26
Regulatory Filings
2026-06-01 English
Updates
Regulatory Filings
2026-06-01 English
Business Responsibility and Sustainability Reporting (BRSR) for FY 2025-26
Environmental & Social Information Classification · 95% confidence The document is a Business Responsibility and Sustainability Report (BRSR) filed under SEBI’s Listing Regulations, containing comprehensive ESG disclosures (environmental, social and governance metrics), assurance statements, management disclosures, KPI performance against sustainability principles. It is not a full annual report or financial statements, nor an announcement of vote results or management change, but an ESG-focused statutory report. Therefore, it fits the Environmental & Social Information category.
2026-06-01 English
Submission of Annual Report for FY 2025-26 and intimation of voting through electronic means
Regulatory Filings
2026-06-01 English
Intimation of Schedule of Investors Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings Classification · 95% confidence The document is a notice to stock exchanges (BSE and NSE) under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) 2015, providing the schedule of upcoming investor meetings. It does not contain financial results, report attachments, or proxy materials, but rather is a routine regulatory announcement of material events (investor meet schedule). This fits the fallback category for general regulatory filings and announcements.
2026-05-30 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 92% confidence The document is an exchange filing under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, providing an intimation of the schedule of investors’ meetings. It does not contain actual financial results or detailed presentations but is a routine compliance announcement to stock exchanges. Therefore, it falls under general regulatory announcements and compliance filings (Regulatory Filings).
2026-05-30 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.